Cell-derived biomimetic nanoparticles for the targeted therapy of ALI/ARDS

Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2019;122:2731–40. https://doi.org/10.1038/s41572-019-0069-0.

Warren MA, Zhao Z, Koyama T, Bastarache JA, Shaver CM, Semler MW, Rice TW, Matthay MA, Calfee CS, Ware LB. Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS. Thorax. 2018;73:840–6. https://doi.org/10.1136/thoraxjnl-2017-211280.

Article  PubMed  Google Scholar 

Baron RM, Levy BD. Recent advances in understanding and treating ARDS. F1000Research. 2016;5:725. https://doi.org/10.12688/f1000research.7646.1.

Yang SC, Tsai YF, Pan YL, Hwang TL. Understanding the role of neutrophils in acute respiratory distress syndrome. J Biomed Sci. 2021;44:439–46. https://doi.org/10.1016/j.bj.2020.09.001.

Article  CAS  Google Scholar 

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. https://doi.org/10.1001/jama.2016.0291.

Article  CAS  PubMed  Google Scholar 

Silva PL, Pelosi P, Rocco PRM. Personalized pharmacological therapy for ARDS: a light at the end of the tunnel. Expert Opin Investig Drugs. 2020;29:49–61. https://doi.org/10.1080/13543784.2020.1699531.

Article  CAS  PubMed  Google Scholar 

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–43. https://doi.org/10.1001/jamainternmed.2020.0994.

Article  CAS  PubMed  Google Scholar 

Murgia X, Cristiane D, Lehr CM. Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics. Eur J Nanomed. 2014;6. https://doi.org/10.1515/ejnm-2014-0019.

Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532–55. https://doi.org/10.1016/j.addr.2006.09.009.

Article  CAS  PubMed  Google Scholar 

Okeke EB, Louttit C, Fry C, Najafabadi AH, Han K, Nemzek J, Moon JJ. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock. Biomaterials. 2020;238:119836. https://doi.org/10.1016/j.biomaterials.2020.119836.

Li SJ, Wang XJ, Hu JB, Kang XQ, Chen L, Xu XL, Ying XY, Jiang SP, Du YZ. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy. Drug Deliv. 2017;24:402–13. https://doi.org/10.1080/10717544.2016.1259369.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasanna P, Rathee S, Upadhyay A, Sulakshana S. Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sci. 2021;276:119428. https://doi.org/10.1016/j.lfs.2021.119428.

Xu H, Wang KQ, Deng YH, Chen DW. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes. Biomaterials. 2010;31:4757–63. https://doi.org/10.1016/j.biomaterials.2010.02.049.

Article  CAS  PubMed  Google Scholar 

Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Artificial exosomes for translational nanomedicine. J Nanobiotechnology. 2021;19:242. https://doi.org/10.1186/s12951-021-00986-2.

Article  PubMed  PubMed Central  Google Scholar 

Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z. Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design. Acta Pharm Sin B. 2021;11:3060–91. https://doi.org/10.1016/j.apsb.2021.04.023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bose RJ, Paulmurugan R, Moon J, Lee SH, Park H. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics. Drug Discov Today. 2018;23:891–9. https://doi.org/10.1016/j.drudis.2018.02.001.

Article  CAS  PubMed  Google Scholar 

Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating technology: a promising strategy for biomedical applications. Nanomicro Lett. 2019;11:100. https://doi.org/10.1007/s40820-019-0330-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 2011;108:10980–5. https://doi.org/10.1073/pnas.1106634108.

Article  PubMed  PubMed Central  Google Scholar 

Liu G, Zhao X, Zhang Y, Xu J, Xu J, Li Y, Min H, Shi J, Zhao Y, Wei J, Wang J, Nie G. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adv Mater. 2019;31:e1900795. https://doi.org/10.1002/adma.201900795.

Sun T, Kwong CHT, Gao C, Wei J, Yue L, Zhang J, Ye RD, Wang R. Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine. Theranostics. 2020;10:10106–19. https://doi.org/10.7150/thno.48448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou K, Yang C, Shi K, Liu Y, Hu D, He X, Yang Y, Chu B, Peng J, Zhou Z, Qian Z. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage. Biomaterials. 2023;295:122036. https://doi.org/10.1016/j.biomaterials.2023.122036.

Yang F, Cabe MH, Ogle SD, Sanchez V, Langert KA. Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication. Sci Rep. 2021;11:23996. https://doi.org/10.1038/s41598-021-03422-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou S, Wang B, Wang C, Wang Q, Zhang L. Cell membrane-coated nanoparticles: research advances. Nanomedicine (Lond). 2020;15:625–41. https://doi.org/10.2217/nnm-2019-0388.

Article  CAS  PubMed  Google Scholar 

Liu C, Zhang W, Li Y, Chang J, Tian F, Zhao F, Ma Y, Sun J. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting. Nano Lett. 2019;19:7836–44. https://doi.org/10.1021/acs.nanolett.9b02841.

Article  CAS  PubMed  Google Scholar 

Rao L, Cai B, Bu LL, Liao QQ, Guo SS, Zhao XZ, Dong WF, Liu W. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11:3496–505. https://doi.org/10.1021/acsnano.7b00133.

Article  CAS  PubMed  Google Scholar 

Bose RJ, Lee SH, Park H. Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments. Drug Discov Today. 2016;21:1303–12. https://doi.org/10.1016/j.drudis.2016.06.005.

Article  CAS  PubMed  Google Scholar 

Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, Simpson RJ. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56:293–304. https://doi.org/10.1016/j.ymeth.2012.01.002.

Article  CAS  PubMed  Google Scholar 

Mao L, Jiang Y, Ouyang H, Feng Y, Li R, Zhang X. Revealing the distribution of aggregation-induced emission nanoparticles via dual-modality imaging with fluorescence and mass spectrometry. Research (Wash DC). 2021;2021:9784053. https://doi.org/10.34133/2021/9784053.

Lu C, Zheng J, Ding Y, Meng Y, Tan F, Gong W, Chu X, Kong X, Gao C. Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy. Drug Deliv. 2021;28:2582–93. https://doi.org/10.1080/10717544.2021.2009936.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, Liao X, Wu W, Wang G. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11:164–80. https://doi.org/10.7150/thno.47841.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Wang H, Long J, Lu Z, Chun C, Li X. Neutrophil membrane-coated therapeutic liposomes for targeted treatment in acute lung injury. Int J Pharm. 2022;624:121971. https://doi.org/10.1016/j.ijpharm.2022.121971.

Park JH, Jiang Y, Zhou J, Gong H. Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs. Sci Adv. 2021;7:eabf7820. https://doi.org/10.1126/sciadv.abf7820.

Li B, Wang W, Song W, Zhao Z, Tan Q, Zhao Z, Tang L, Zhu T, Yin J, Bai J. Antiviral and anti-inflammatory treatment with multifunctional alveolar macrophage-like nanoparticles in a surrogate mouse model of COVID-19. Adv Sci. 2021;8:2002556. https://doi.org/10.1002/advs.202003556.

Wang K, Lei Y, Xia D, Xu P, Zhu T, Jiang Z, Ma Y. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation. Colloids Surf B Biointerfaces. 2020;188:110755. https://doi.org/10.1016/j.colsurfb.2019.110755.

Shen S, Han F, Yuan A, Wu L, Cao J, Qian J, Qi X, Yan Y, Ge Y. Engineered nanoparticles disguised as macrophages for trapping lipopolysaccharide and preventing endotoxemia. Biomaterials. 2019;189:60–8. https://doi.org/10.1016/j.biomaterials.2018.10.029.

Article  CAS  PubMed  Google Scholar 

Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology. 2021;19:173. https://doi.org/10.1186/s12951-021-00926-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Guo C, Chen Q, Su Y, Guo H, Liu R, Sun C, Mi S, Wang J, Chen D. Improvement of pneumonia by curcumin-loaded bionanosystems based on platycodon grandiflorum polysaccharides via calming cytokine storm. Int J Biol Macromol. 2022;202:691–706. https://doi.org/10.1016/j.ijbiomac.2022.01.194.

Article  CAS  PubMed  Google Scholar 

Wei X, Ran D, Campeau A, Xiao C, Zhou J, Dehaini D, Jiang Y, Kroll AV, Zhang Q, Gao W, Gonzalez DJ, Fang RH, Zhang L. Multiantigenic nanotoxoids for antivirulence vaccination against antibiotic-resistant gram-negative bacteria. Nano Lett. 2019;19:4760–9. https://doi.org/10.1021/acs.nanolett.9b01844.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH, Fang RH, Gao W, Griffiths A, Zhang L. Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett. 2020;20:5570–4. https://doi.org/10.1021/acs.nanolett.0c02278.

Article  CAS  PubMed 

Comments (0)

No login
gif